Luspatercept as a Treatment Option in MDS

Opinion
Video

Jamie L. Koprivnikar, MD, reviews luspatercept as a treatment option in myelodysplastic syndrome and the adverse events most frequently seen with her patients in clinical practice.

Related Videos
Brooke Peters, PharmD, BCOP, a clinical pharmacist
Expert on DLBCL
Expert on DLBCL
Expert on DLBCL
Expert on DLBCL
Expert on DLBCL
Expert on DLBCL
Expert on DLBCL
Related Content